Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
1999-05-28
2001-02-27
Cintins, Marianne M. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S053000, C514S546000, C514S882000
Reexamination Certificate
active
06194455
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The instant invention relates generally to compositions for treating skin ulcers and particularly to compositions for medical or veterinary use containing sucralfate in combination with a topical anesthetic for treating skin ulcers.
2. Description of the Related Art
Compositions containing sucralfate or topical anesthetics are known in the art. For example, U.S. Pat. No. 5,246,697 (Conte, U., et al., Sep. 12, 1993) discloses the use of a sucralfate-containing gel as a vehicle for the application of drugs having topic activity.
U.S. Pat. No. 5,411,738 (Hind, H., May 2, 1995) discloses a composition and method for alleviating the pain associated with shingles utilizing the topical administration of lidocaine.
U.S. Pat. No. 5,478,814 (Packman, E. W., May 2, 1995) discloses a composition and method for treating hemorrhoids utilizing the topical administration of sucralfate in combination with a topically therapeutic agent, including an anesthetic.
U.S. Pat. No. 5,707,653 (Goldberg, A. H., Jan. 13, 1998) discloses a composition for treating internal or external ulcers which contains sucralfate in combination with an antibiotic.
SUMMARY OF THE INVENTION
The present invention is concerned with compositions for treating skin ulcers and particularly to compositions for medical or veterinary use containing sucralfate in combination with a topical anesthetic for treating skin ulcers.
A primary object of the present invention is to provide a composition and method for treating a wide variety of skin ulcers which utilizes a sucralfate in combination with lidocaine.
Another object of the present invention is to provide a composition and method for preventing the formation of herpes ulcers.
An additional object of the present invention is to provide a composition and method for promoting healing of diabetic ulcers.
Another object of the present invention is to provide a composition for treating skin ulcers which contains sucralfate in combination with a topical anesthetic and an antibiotic.
A further object of the present invention is to provide a composition for treating skin ulcers which provides both immediate relief from pain and long-lasting healing of the ulcer.
Another object of the present invention is to provide a composition for treating skin conditions such as acne, eczema, shingles, psoriasis, ringworm, jock itch, athlete's foot, burns and abrasions, which contains sucralfate in combination with one or more antibiotics, a topical anesthetic, or both.
Still another object of the invention is to provide a composition for treating sinus conditions containing sucralfate in combination with lidocaine.
The foregoing and other objects, advantages and characterizing features will become apparent from the following description of certain illustrative embodiments of the invention.
The novel features which are considered characteristic for the invention are set forth in the appended claims. The invention itself, however, both as to its construction and its method of operation, together with additional objects and advantages thereof, will be best understood from the following description of the specific embodiments when read and understood in connection with the accompanying drawings. Attention is called to the fact, however, that the drawings are illustrative only, and that changes may be made in the specific construction illustrated and described within the scope of the appended claims
REFERENCES:
patent: 4945084 (1990-07-01), Packman
patent: 5102870 (1992-04-01), Florine et al.
patent: 5196405 (1993-03-01), Packman
patent: 5246697 (1993-09-01), Conte et al.
patent: 5411738 (1995-05-01), Hind
patent: 5457128 (1995-10-01), Yanaqawa
patent: 5478814 (1995-12-01), Packman
patent: 5707653 (1998-01-01), Goldberg
patent: 5709873 (1998-01-01), Bar-Shalom et al.
patent: 5714165 (1998-02-01), Repka et al.
patent: 5977087 (1999-11-01), Pehrson, Sr. et al.
patent: 89/00047 (1989-01-01), None
Meredith et al., Sucralfate for radiation mucocitis . . . , Int. J. Radiat. Oncol., Phys. vol. 37/2, pp. 275-279, (1997).
Nguyen et al., Muciadhesive semisolid . . . , Eur. J. Biopharm. vol. 42/2, pp. 133-137, (1996).
Hondalus et al.,Septicemic salmonellosis. . . , J. of The American Vet.Med. Assoc. vol. 1192/4, pp. 527-529, (1988).
Cintins Marianne M.
Kim Vickie
Kroll Michael I.
LandOfFree
Topical medicament for treating skin ulcers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical medicament for treating skin ulcers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical medicament for treating skin ulcers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2615267